Recurrent cervicitis can require a different testing discussion. This article focuses on when Mgen is relevant in women and what its result cannot tell you.
Everyday names and related terms
Mycoplasma genitalium, M. genitalium, Mgen or MG. It is not the same bacterium as M. hominis.
Cervicitis is not always chlamydia or gonorrhea
Mgen can be associated with cervicitis and PID. Discharge, bleeding after sex or pelvic pain can occur, but they do not identify Mgen specifically. Other established causes should be assessed as well. Clinical reference: CDC — Mycoplasma genitalium: STI Treatment Guidelines · CDC — Urethritis and Cervicitis: STI Treatment Guidelines
How the result should be interpreted
CDC recommends testing women with recurrent cervicitis and considering Mgen testing in PID. Routine screening of people without symptoms is not recommended. Clinical reference: CDC — Mycoplasma genitalium: STI Treatment Guidelines · CDC — Urethritis and Cervicitis: STI Treatment Guidelines
The important limitation
A positive vaginal test does not measure damage to the fallopian tubes. Persistent pelvic pain or fertility concerns need clinical assessment beyond a molecular result.
The clinical question behind this search
In women, cervicitis can be silent or cause discharge, bleeding and pelvic discomfort. Pelvic pain raises the need to assess for PID rather than relying on a panel alone.
| Cause | Mycoplasma genitalium |
|---|---|
| How it spreads / is acquired | sexual contact; evidence is strongest for genital transmission |
| When symptoms may appear | There is no dependable symptom-onset timetable for an individual. Infection can be asymptomatic, and symptoms may persist or recur. |
| Useful distinguishing clue | Persistent or recurrent urethritis after common causes have been considered is a particularly useful clue, but laboratory confirmation is needed. |
| Common symptom overlap | chlamydia, gonorrhea, trichomoniasis, UTI, cervicitis and pelvic inflammatory disease |
Symptoms: common does not mean specific
Possible findings include urethral discharge or irritation, burning urination, cervicitis, bleeding after sex, pelvic pain, or no symptoms. None of these, alone, confirms Mycoplasma genitalium. Symptoms may be absent, may appear later than expected, or may improve while the infection or underlying problem remains.
What can look similar?
The differential diagnosis includes chlamydia, gonorrhea, trichomoniasis, UTI, cervicitis and pelvic inflammatory disease. Coinfection is also possible, which is why a clinician may recommend more than one target or more than one sample site.
How is it diagnosed?
Use a validated molecular assay, such as PCR where appropriate, on an appropriate urine or swab sample. Culture is not practical because the organism grows extremely slowly. CDC does not recommend routine screening of asymptomatic people.
When should you see a doctor promptly?
- Severe pelvic, abdominal or testicular pain
- Fever, faintness, rapidly worsening symptoms or pregnancy
- A new genital ulcer, blister or widespread rash
- Symptoms after sexual assault, or possible exposure to HIV
Questions readers ask
Is routine Mgen screening recommended without symptoms?
No. CDC does not recommend screening asymptomatic people.
Does a positive Mgen test show fallopian-tube damage?
A positive vaginal test does not measure damage to the fallopian tubes. Persistent pelvic pain or fertility concerns need clinical assessment beyond a molecular result.
From symptoms to the right sample
CDC recommends testing women with recurrent cervicitis and considering Mgen testing in PID. Routine screening of people without symptoms is not recommended. If your next step is an STD test in Dubai, review the targets in Qurapid’s 14-target panel before choosing your sample. Results are available the same day. Urgent symptoms require examination; do not delay medical care while arranging a panel.
In Dubai and across the UAE, Qurapid’s laboratory partners include PHD/ALBORG, MDC and Genex Lab. The partner network covers all seven emirates. Confirm the collection location, specimen requirements and availability when booking.
References
- CDC — Mycoplasma genitalium: STI Treatment Guidelines
- CDC — Urethritis and Cervicitis: STI Treatment Guidelines